Carlyle-backed Indegene makes another overseas acquisition
Indegene, a technology-led healthcare solutions provider to biopharmaceutical, biotech and medical devices companies, has acquired another overseas company to ramp up its service offerings. The Indian company, which is backed by US-based private equity firm Carlyle, has purchased medical writing consultancy firm Trilogy Writing & Consulting GmbH. Indegene said in a statement Trilogy's acquisition will ......
Deals Digest: Funding momentum slows further in shorter week
Capital raised by private equity and venture capital-backed startups slipped for the second consecutive week, as overall activity was subdued due to a three-day working week on account of Holi and Good Friday holidays. Overall funding raised by startups and companies backed by altrnative investors nearly halved this week to $236 ......
Carlyle makes a partial exit from IPO-bound Indegene
Private equity firm Carlyle has trimmed its stake in Indegene, just two years after teaming up with another investment firm to joint betting $200 million (Rs 1,500 crore then) on the healthtech venture. Carlyle had joined hands with Brighton Park Capital, a private investment firm that focuses on software, information services, ......
Why Avendus is expanding its investment focus on manufacturing sector
Avendus Future Leaders Fund, the late-stage investment arm of financial services firm Avendus, is expanding the list of sectors it focuses on to include manufacturing, as it nears the end of deployment period for its second fund, a top executive told VCCircle. The firm, which is currently investing from the Avendus ......
Indian healthtech in a soup as investors turn cautious on elusive profitability, lack of scale
The Indian healthtech sector may be facing a time of reckoning as investment dries up gradually. As the $6.5 billion sector grapples with a plethora of issues ranging from delayed profitability, stagnant scale to offline competition, investors now seek businesses that are relatively closer or have already turned the corner and ......
Carlyle strikes first full exit in India this year
Private equity firm Carlyle Group, which kicked off this year with a control deal for VLCC, has now struck its first full exit after signing off from two Indian portfolio companies- hospital chain Medanta and SBI Cards in 2022. The PE firm that also marked a partial exit from IPO-bound Indegene, ......
Weekly Deal Wrap: Meet chart-toppers Indegene, Teen Patti maker and Zetwerk
Technology as a theme dominated the deal charts in the first week of February as Indegene, Teen Patti developer Moonfrog Labs and Zetwerk came out tops across the spectrum. Indegene topped the PE chart with a $200 million (Rs 1,461 crore) investment from new investors -- global private equity fund Carlyle ......
Deals Digest: PE/VC funding value doubles due to HDFC Credila deal
This week’s overall funding doubled in value terms, aided by the big-ticket private equity buyout of HDFC’s education lending arm HDFC Credila, which was acquired by buyout group BPEA EQT and homegrown PE firm ChrysCapital for $1.1 billion (Rs 9,060.5 crore). ChrysCapital committed Rs 2,000 crore for the deal. Total funding ......
Deals Digest: Startup funding value halves this week; M&A picks up pace
The total value of private equity and venture capital deals in India almost halved this week from the previous five-day period due to an absence of any big-ticket transaction. Startups managed to raise $106.7 million in the week through Friday in comparison to $204.4 million in the previous week, according to ......
Indegene close to buying two US health-tech firms
Bangalore-headquartered Indegene Lifesystems Pvt Ltd, which provides clinical, commercial and marketing solutions to global lifescience and pharmaceutical companies, is set to acquire two small firms in the healthcare technology space in US, its co-founder & CEO told VCCircle.“We continue to look at acquisitions in the healthcare and physician engagement. At ......
